These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
530 related items for PubMed ID: 20530506
1. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. Jacqueline C, Amador G, Caillon J, Le Mabecque V, Batard E, Miègeville AF, Biek D, Ge Y, Potel G, Hamel A. J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506 [Abstract] [Full Text] [Related]
2. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model. Yin LY, Calhoun JH, Thomas TS, Wirtz ED. J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292 [Abstract] [Full Text] [Related]
6. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model. Conaughty JM, Chen J, Martinez OV, Chiappetta G, Brookfield KF, Eismont FJ. Spine (Phila Pa 1976); 2006 Oct 15; 31(22):E830-2. PubMed ID: 17047530 [Abstract] [Full Text] [Related]
7. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Vidaillac C, Leonard SN, Rybak MJ. Int J Antimicrob Agents; 2010 Jun 15; 35(6):527-30. PubMed ID: 20346632 [Abstract] [Full Text] [Related]
8. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C. Biomaterials; 2005 Sep 15; 26(25):5251-8. PubMed ID: 15792552 [Abstract] [Full Text] [Related]
9. Empiric antibiotic therapy for acute osteoarticular infections with suspected methicillin-resistant Staphylococcus aureus or Kingella. Saphyakhajon P, Joshi AY, Huskins WC, Henry NK, Boyce TG. Pediatr Infect Dis J; 2008 Aug 15; 27(8):765-7. PubMed ID: 18600193 [Abstract] [Full Text] [Related]
10. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Twilla JD, Gelfand MS, Cleveland KO, Usery JB. J Antimicrob Chemother; 2011 Nov 15; 66(11):2675-7. PubMed ID: 21831987 [No Abstract] [Full Text] [Related]
12. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin. Kanellakopoulou K, Galanopoulos I, Soranoglou V, Tsaganos T, Tziortzioti V, Maris I, Papalois A, Giamarellou H, Giamarellos-Bourboulis EJ. Int J Antimicrob Agents; 2009 Apr 15; 33(4):354-9. PubMed ID: 19097865 [Abstract] [Full Text] [Related]
13. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE, Wells EM. Curr Med Res Opin; 2010 Mar 15; 26(3):571-88. PubMed ID: 20055750 [Abstract] [Full Text] [Related]
20. Implant stability in the treatment of MRSA bone implant infections with linezolid versus vancomycin in a rabbit model. Schroeder K, Simank HG, Lorenz H, Swoboda S, Geiss HK, Helbig L. J Orthop Res; 2012 Feb 15; 30(2):190-5. PubMed ID: 21815204 [Abstract] [Full Text] [Related] Page: [Next] [New Search]